Navigation Links
Masimo Reports First Quarter 2008 Financial Results
Date:4/29/2008

/p>

Property and equipment, net 11,164 11,133

Deferred tax assets 5,332 5,332

Restricted cash 513 518

Intangible assets, net 5,589 6,011

Goodwill 448 448

Other assets 2,576 2,547

Total assets $235,511 $227,152

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities

Accounts payable $14,640 $16,929

Accrued compensation 12,409 10,244

Accrued liabilities 6,211 5,542

Dividends payable 183 183

Deferred revenue 16,827 20,983

Current portion of long-term debt 11,539 900

Total current liabilities 61,809 54,781

Deferred revenue 366 339

Long-term debt, less current portion 19,502 532

Other liabilities 3,768 3,794

Total liabilities 85,445 59,446

Commitments and contingencies

Stockholders' equity

Common stock 55 56

Treasury stock (1,209) (1,209)

Additional paid-in capital 143,297 151,723

Accumulated other comprehensive loss (1,034) (612)

Retained earnings 8,957 17,748

Total stockholders' equity 150,066 167,706

Total
'/>"/>

SOURCE Masimo Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Atom Medical Adopts Masimo Rainbow SET Technology
2. Schiller AG Adopts Masimo Rainbow SET as Their Technology Platform of Choice for Patient Monitoring Devices Worldwide
3. Masimo to Present at Citi Investment Research 5th Annual Small & Mid-Cap Conference
4. Masimo Reports Fourth Quarter 2007 and Full Year 2007 Financial Results
5. Masimo Announces Continuous Noninvasive Total Hemoglobin
6. Masimo Awarded Multi-Year Pulse Oximetry Agreement with HealthTrust Purchasing Group
7. Abington Memorial Hospital Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology
8. Masimo Corporation Given Approval to Market the Masimo Rad-57 Pulse CO-Oximeter in Japan
9. Masimo to Report Third Quarter 2007 Financial Results on October 30, 2007
10. Masimo Launches Patient SafetyNet and Showcases the Rainbow SET Upgradable Noninvasive Monitoring Platform at 2007 ASA Annual Meeting
11. Masimo Reports Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... PARIS and NEW YORK ... data from its open-label pilot study of mazindol in ... Design, Development and Therapy in December 2014 . ... of mazindol in children with attention deficit/hyperactivity disorder" ( ... 2014 Dec 1;8:2321-2332. eCollection 2014 ) ...
(Date:12/22/2014)... , Dec. 22, 2014   ... a developer of pathogen-specific therapies for serious ... protecting the microbiome, today announced positive topline ... 1a clinical trial of SYN-004, the Company,s ... of Clostridium difficile (C. difficile) ...
(Date:12/22/2014)... 2014  Alternative Energy & Environmental Solutions, Inc., ... a letter of intent to acquire BioTechPharma Corporation, ... a nanotechnology-based development platform used to create drug ... on-site collection and testing to identify infectious disease, ... an immediate, non-invasive and cost-effective manner. ...
(Date:12/22/2014)... , Dec. 22, 2014  ( www.competitivehealth.com ) ... an online medical bill review and advocacy service, has ... the FREE WellCard Savings discount health services marketplace. ... that was more than they expected to pay. As ... health care costs, WellCard Savings is pleased to offer ...
Breaking Biology Technology:Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 2Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 2Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 4Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 5ALNE Announces Intention To Acquire BioTechPharma 2WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2
... China, Sept. 24 /PRNewswire-Asia-FirstCall/ -- China Biologic,Products, Inc. ... "Company"),one of the leading plasma-based pharmaceutical companies in ... on September 11, 2009, the,Company entered into a ... Blood Transfusion (the "IBT") based in Chengdu, Sichuan ...
... Mich., Sept. 24 Neogen Corporation (Nasdaq: NEOG ) ... 2010, which ended Aug. 31, increased 12% from the previous year,s ... the prior year,s $3,733,000 to $4,395,000, or to $0.29 per share ... , Neogen,s first quarter revenues, net income, and ...
... , ... QTube is a video-based learning tool that ... researchers and scientists. Initial QTube videos include imaging techniques such ... such as making live intensity measurements with multichannel products such as ...
Cached Biology Technology:China Biologic Products Enters into a Strategic Research and Development Agreement with IBT of CAMS 2China Biologic Products Enters into a Strategic Research and Development Agreement with IBT of CAMS 3China Biologic Products Enters into a Strategic Research and Development Agreement with IBT of CAMS 4Neogen Reports 18% Increase in Net Income, 12% Increase in Revenues 2Neogen Reports 18% Increase in Net Income, 12% Increase in Revenues 3Neogen Reports 18% Increase in Net Income, 12% Increase in Revenues 4Neogen Reports 18% Increase in Net Income, 12% Increase in Revenues 5Neogen Reports 18% Increase in Net Income, 12% Increase in Revenues 6QImaging Introduces "QTube," a Video-based Learning Tool for Scientific & Industrial Digital Imaging 2
(Date:11/21/2014)... YORK , Nov. 19, 2014  Earlier this ... at New York College, and one of the most ... biosensor signals that are transmitted from Smartphones to third ... were Smartphones and has one of the earliest known ... discussing its usage in the military, child care, elder ...
(Date:11/21/2014)... , Nov. 20, 2014   Atmel® Corporation ... microcontroller (MCU) and touch technology solutions, today launched the ... with the widest V cc range from ... accuracy and faster I 2 C bus communication speeds, ... EEPROM memory making them ideal for consumer, industrial, computer, ...
(Date:11/18/2014)... Md. , Nov. 17, 2014 The Parenteral ... and U.S. regulatory agencies will speak and at least seven ... Metrics Conference at the Omni Shoreham Hotel in ... pleased once again to have significant support from the regulatory ... Europe in our effort to help ...
Breaking Biology News(10 mins):Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4FDA's Janet Woodcock, EMA's Emer Cooke Headline PDA Quality Metrics Conference 2
... Basin forest is the second largest tract of rainforest ... 60 million people providing food and income for ... unique ecosystems and regulating the flow of the major ... being cleared at an alarming rate amid global demand ...
... University of London have sequenced the genetic code of a ... British birch populations. The genome, which is around ... of traits such as disease resistance and growth shape. ... the world, with huge ecological and commercial importance. They are ...
... when it comes to the future of their young, a strategy ... Researchers from Durham University, UK, and the University of St ... seal mothers are flexible in the parenting style they adopt and ... safe and steady. The study is the first to ...
Cached Biology News:Feature package of Congo Basin forest photos, stories & videos 2Researchers decode birch tree genome sequence for the first time 2Seals gamble with their pups' futures 2Seals gamble with their pups' futures 3
... Assay Kits are ideal for studying or ... GR Competitor Assay Kits contain partially purified ... of the following proprietary fluorescent glucocorticoid Fluormone ... (red assay kit), or GS Far Red ...
... complete kit contains enough separation ... a total of 5 x ... includes the StemSep red magnet ... and buffers for the specific ...
... * Source rat ... T25 plated cells $550.00, * ... 120 population doublings, * This ... complete ,growth medium M55007-08 and ...
... Tissue Arrays are intended for laboratory research ... fixed in neutral buffered formalin and embedded ... was performed by certified pathologists. Tissue ... and relocated into a new recipient paraffin ...
Biology Products: